A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/9033626

Int. J. Cancer 1997 Jan 27 70 3 269-77

Download in:

View as

Triples

General Info

PMID
9033626